Bio-Techne
TECH
#1341
Rank
$13.15 B
Marketcap
$83.50
Share price
-0.77%
Change (1 day)
2.98%
Change (1 year)
Bio-Techne Corporation is an American holding company for biotechnology and clinical diagnostic brands. The company's brands portfolio includes R&D Systems, Novus Biologicals, Tocris Bioscience, ProteinSimple, Exosome Diagnostics, BiosPacific, Cliniqa, Advanced Cell Diagnostics, RNA Medical, Bionostics and BostonBiochem.

Revenue for Bio-Techne (TECH)

Revenue in 2023 (TTM): $1.14 B

According to Bio-Techne's latest financial reports the company's current revenue (TTM) is $1.14 B. In 2022 the company made a revenue of $1.11 B an increase over the years 2021 revenue that were of $1.02 B.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Bio-Techne from 2001 to 2023

Annual revenue

Year Revenue Change
2023 (TTM) $1.14 B2.25%
2022 $1.11 B8.77%
2021 $1.02 B28.86%
2020 $0.79 B7.29%
2019 $0.74 B9.24%
2018 $0.68 B13.74%
2017 $0.59 B13.49%
2016 $0.52 B13.55%
2015 $0.46 B13.86%
2014 $0.40 B23.73%
2013 $0.33 B5.68%
2012 $0.31 B1.91%
2011 $0.30 B12.44%
2010 $0.27 B2.96%
2009 $0.26 B-1.37%
2008 $0.26 B12.46%
2007 $0.23 B12.76%
2006 $0.21 B10.73%
2005 $0.19 B13.71%
2004 $0.16 B9.61%
2003 $0.15 B11.36%
2002 $0.13 B12.99%
2001 $0.12 B

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
$42.85 B 3,642.97%๐Ÿ‡บ๐Ÿ‡ธ USA
$19.49 B 1,602.36%๐Ÿ‡บ๐Ÿ‡ธ USA
$69.52 B 5,971.62%๐Ÿ‡บ๐Ÿ‡ธ USA
$22.51 B 1,866.73%๐Ÿ‡บ๐Ÿ‡ธ USA
$1.93 B 69.32%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands
$12.8 M-98.88%๐Ÿ‡บ๐Ÿ‡ธ USA
$2.67 B 133.30%๐Ÿ‡บ๐Ÿ‡ธ USA